March 4, 2013
|
Story
A trio of scientists—including two alumni of the Robert Wood Johnson Foundation (RWJF) Clinical Scholars program—published an article on March 1, 2013, shedding new light why some hospitals are better able to help vulnerable newborns survive.
December 12, 2012
|
News Release
Study identifies factors that keep new mothers from getting the sleep they need.
February 1, 2012
|
Journal Article
This study measures the oxygen extraction fraction (OEF) to gauge metabolic abnormalities by using a magnetic resonance (MR) technique. This study supports previous studies' findings: OEF is decreased in traumatic brain injury (TBI) patients, and correlates with the severity of the injury.
February 28, 2012
|
Story
With RWJF support, Harold Amos Scholar researches a promising approach to treating traumatic brain injury in children and adolescents.
December 3, 2012
|
Report
The report presents the most up-to-date estimates available on Medicaid/CHIP participation rates, and examines how participation, eligibility, and rates of being insured have changed among children between 2008 and 2010 and examines participation rates among parents.
March 1, 2013
|
Journal Article
NICU mortality risk-adjustment scores vary widely by the data collected and the timing of collection.
March 1, 2013
|
Journal Article
No significant changes were seen in management of bronchiolitis after guidelines recommended against medications and x-rays for infants and toddlers.
February 1, 2010
|
Journal Article
The Youth Risk Behavior Survey reported that roughly 14.5 percent of U.S. high school students considered suicide in 2006. This study used focus groups to uncover common beliefs about teen suicide
April 1, 2006
|
Journal Article
A number of negative health consequences in children have been associated with overexposure to media. The goal of this research was to better understand parental approaches to influencing children's use of media (television, video and computer). An ...
April 1, 2006
|
Journal Article
In 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for all children aged 2 to 23 months. This study compares the rates of invasive pneumococcal disease (IPD) in young infants before and after the addition of PC ...